These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 31631422

  • 1. PTH determination in hemodialyzed patients-A laboratory perspective.
    Cavalier E, Souberbielle JC, Delanaye P.
    Semin Dial; 2019 Nov; 32(6):490-492. PubMed ID: 31631422
    [Abstract] [Full Text] [Related]

  • 2. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P.
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T, Ishida M, Fukagawa M.
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [Abstract] [Full Text] [Related]

  • 5. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 6. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
    Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K.
    Pediatr Nephrol; 2019 Jan; 34(1):107-115. PubMed ID: 30267239
    [Abstract] [Full Text] [Related]

  • 10. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T, Sci B.
    Nefrologia; 2003 Jan; 23 Suppl 2():69-72. PubMed ID: 12778858
    [Abstract] [Full Text] [Related]

  • 11. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.
    Johansen KL, Chertow GM.
    J Ren Nutr; 2007 Sep; 17(5):305-13. PubMed ID: 17720099
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG.
    Blood Purif; 2003 Sep; 21(1):118-23. PubMed ID: 12596757
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG.
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [Abstract] [Full Text] [Related]

  • 16. Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.
    Herberth J, Branscum AJ, Mawad H, Cantor T, Monier-Faugere MC, Malluche HH.
    Am J Kidney Dis; 2010 May; 55(5):897-906. PubMed ID: 20347512
    [Abstract] [Full Text] [Related]

  • 17. Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy.
    Gentry J, Webb J, Davenport D, Malluche HH.
    Clin Nephrol; 2016 Jul; 86(7):9-17. PubMed ID: 27191663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
    Neri L, Kreuzberg U, Bellocchio F, Brancaccio D, Barbieri C, Canaud B, Stuard S, Ketteler M.
    Nephrol Dial Transplant; 2019 Apr 01; 34(4):682-691. PubMed ID: 30165528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.